West End Advisors, LLC Gilead Sciences, Inc. Transaction History

West End Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of West End Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, West End Advisors, LLC holds 14 shares of GILD stock, worth $1,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 16 12.5%

Holding current value

$1,233

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$66.59 - $83.99 $133 - $167	-2 Reduced 12.5%	14 $1,000
Q2 2024 Jul 29, 2024	SELL	$63.15 - $72.88 $252 - $291	-4 Reduced 20.0%	16 $1,000
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $71 - $87	1 Added 5.26%	20 $1,000
Q4 2023 Jan 18, 2024	BUY	$73.27 - $83.09 $146 - $166	2 Added 11.76%	19 $1,000
Q3 2023 Oct 19, 2023	BUY	$73.94 - $80.67 $1,256 - $1,371	17 New	17 $1,000
Q1 2023 Apr 28, 2023	BUY	$77.31 - $88.08 $77 - $88	1 Added 6.67%	16 $1,000
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $62 - $89	-1 Reduced 6.25%	15 $1,000
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $59 - $68	1 Added 6.67%	16 $1,000
Q2 2022 Jul 28, 2022	BUY	$57.72 - $65.01 $173 - $195	3 Added 25.0%	15 $927,000
Q1 2022 Apr 26, 2022	BUY	$57.92 - $72.58 $115 - $145	2 Added 20.0%	12 $713,000
Q4 2021 Jan 14, 2022	BUY	$64.88 - $73.64 $64 - $73	1 Added 11.11%	10 $726,000
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $67 - $73	-1 Reduced 10.0%	9 $628,000
Q2 2021 Jul 15, 2021	BUY	$63.47 - $69.35 $634 - $693	10 New	10 $688,000
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $28.5 Million - $36.5 Million	-454,472 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $1.7 Million - $1.87 Million	-27,531 Reduced 5.71%	454,472 $29.5 Billion
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $1.52 Million - $1.67 Million	-24,245 Reduced 4.79%	482,003 $30.5 Billion
Q2 2019 Jul 23, 2019	SELL	$61.87 - $69.38 $1.82 Million - $2.04 Million	-29,445 Reduced 5.5%	506,248 $34.2 Billion
Q1 2019 May 03, 2019	BUY	$62.53 - $70.05 $5.62 Million - $6.3 Million	89,886 Added 20.16%	535,693 $34.8 Billion
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $4.49 Million - $5.86 Million	-74,155 Reduced 14.26%	445,807 $27.9 Billion
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $918,799 - $1.02 Million	-12,890 Reduced 2.42%	519,962 $40.1 Billion
Q2 2018 Jul 26, 2018	SELL	$64.88 - $75.68 $1.1 Million - $1.28 Million	-16,906 Reduced 3.08%	532,852 $37.7 Billion
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $266,375 - $324,741	3,657 Added 0.67%	549,758 $41.4 Billion
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $11.1 Million - $13 Million	-155,362 Reduced 22.15%	546,101 $39.1 Billion
Q3 2017 Nov 03, 2017	SELL	$72.11 - $85.47 $3.89 Million - $4.62 Million	-54,002 Reduced 7.15%	701,463 $56.8 Billion
Q2 2017 Aug 09, 2017	BUY	N/A	755,465	755,465 $53.5 Billion

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.

Account

West End Advisors, LLC Gilead Sciences, Inc. Transaction History